Ingress-health published a patient preference study in AF regarding different treatment options

Between January and October 2014, 647 patients with non-valvular AF were included by 57 practitioners and 486 AF patients could be interviewed. The results showed that when deciding about an anticoagulation treatment, AF patients prefer treatments that can be taken once daily, that do not require any bridging in case of surgeries, and do not have interactions with food/nutrition. Frequency of intake is the most important attribute from a patient’s perspective with once daily intake preferred compared to twice daily intake.

Read our new publication.